Differential Inhibition of Cutaneous T-Cell-Mediated Reactions and Epidermal Cell Proliferation by Cyclosporin A, FK-506, and Rapamycin
- 1 January 1994
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 102 (1), 84-88
- https://doi.org/10.1111/1523-1747.ep12371737
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The spectrum of action of new immunosuppressive drugsClinical and Experimental Immunology, 1992
- Cyclosporin ointment for psoriasis and atopic dermatitisThe Lancet, 1992
- Fk 506 and Autoimmune Disease: Perspective and ProspectsAutoimmunity, 1992
- Topical cyclosporin A treatment in psoriasis and other dermatological diseases: Theoretical and practical aspectsJournal of Dermatological Treatment, 1992
- Rapamycin: FK506's fraternal twin or distant cousin?Immunology Today, 1991
- PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCINTransplantation, 1991
- SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITROTransplantation, 1991
- The Role of Immune System in the Pathogenesis of PsoriasisJournal of Investigative Dermatology, 1990
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989
- Cyclosporin A and skin diseasePublished by Springer Nature ,1989